Oncology: Cancer Treatment News | Boehringer Ingelheim

28.02.2013	Rare disease day: Boehringer Ingelheim announces initiation of pivotal trial investigating volasertib* in patients with acute myeloid leukaemia - For NON-US media only
16.01.2013	U.S. FDA Grants Priority Review to Boehringer Ingelheim’s Afatinib* NDA for EGFR Mutation-Positive Advanced NSCLC - For NON-U.S. Media Only
10.12.2012	Boehringer Ingelheim to initiate Phase III study in leukaemia with its compound volasertib* based on positive Phase II results - For NON-US media only
20.09.2012	Boehringer Ingelheim submits first oncology compound, afatinib* for European approval - For NON-US media only
04.06.2012	Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial - For NON-US media only

28.02.2013

Rare disease day: Boehringer Ingelheim announces initiation of pivotal trial investigating volasertib* in patients with acute myeloid leukaemia

- For NON-US media only

16.01.2013

U.S. FDA Grants Priority Review to Boehringer Ingelheim’s Afatinib* NDA for EGFR Mutation-Positive Advanced NSCLC

- For NON-U.S. Media Only

10.12.2012

Boehringer Ingelheim to initiate Phase III study in leukaemia with its compound volasertib* based on positive Phase II results

- For NON-US media only

20.09.2012

Boehringer Ingelheim submits first oncology compound, afatinib* for European approval

- For NON-US media only

04.06.2012

Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial

- For NON-US media only

Non small cell lung cancer overview (David Ross Camidge)
- Watch video(FLV)
Importance of EGFR Mutation Testing (Vera Hirsh)
- Watch video(FLV)
Personalising cancer care and the future of cancer treatments (John Heymach)
- Watch video(FLV)
LUX-Lung 3 Results (James Yang)
- Watch video(FLV)
Afatinib (Thomas Lynch)
- Watch video(FLV)
Head and Neck Cancer Treatments (Ezra Cohen)
- Watch video(FLV)

Image of a tumor
- Download 300dpi (128Kb)
A tumor needs oxigen and nutrition to grow
- Download 300dpi (1756Kb)
Angiogenesis: Vessels invading the tumor transport oxigen and nutrition
- Download 300dpi (ZIP - 2032Kb)
Signal transduction: a ligand binds to a growth factor receptor and initiates growth signalling cascade
- Download 300dpi (ZIP - 1628Kb)
Angiogenesis Inhibition: Vessels degenerate or withdraw from tumor
- Download 300dpi (ZIP - 2384Kb)
Research Laboratory for Oncology
- Download 300dpi (ZIP - 199Kb)
Laboratory work in Research and Development
- Download 300dpi (ZIP - 2046Kb)
R&D Laboratory Work
- Download 300dpi (2357Kb)
ErbB Family Blockade And Afatinib
- Download 300dpi (1996Kb)
Angiokinase Inhibition and Nintedanib (BIBF 1120)
- Download 300dpi (1864Kb)